| Year |
Citation |
Score |
| 2019 |
McNeill AM, Hudock RL, Foy AMH, Shanley R, Semrud-Clikeman M, Pierpont ME, Berry SA, Sommer K, Moertel CL, Pierpont EI. Emotional functioning among children with neurofibromatosis type 1 or Noonan syndrome. American Journal of Medical Genetics. Part A. PMID 31566897 DOI: 10.1002/Ajmg.A.61361 |
0.338 |
|
| 2019 |
Orchard PJ, Markowski TW, Higgins L, Raymond GV, Nascene DR, Miller WP, Pierpont EI, Lund TC. Association between APOE4 and biomarkers in cerebral adrenoleukodystrophy. Scientific Reports. 9: 7858. PMID 31133696 DOI: 10.1038/S41598-019-44140-3 |
0.311 |
|
| 2018 |
Rosser TC, Edgin JO, Capone GT, Hamilton DR, Allen EG, Dooley KJ, Anand P, Strang JF, Armour AC, Frank-Crawford MA, Channell MM, Pierpont EI, Feingold E, Maslen CL, Reeves RH, et al. Associations Between Medical History, Cognition, and Behavior in Youth With Down Syndrome: A Report From the Down Syndrome Cognition Project. American Journal On Intellectual and Developmental Disabilities. 123: 514-528. PMID 30421968 DOI: 10.1352/1944-7558-123.6.514 |
0.42 |
|
| 2018 |
Pierpont EI, Hudock RL, Foy AM, Semrud-Clikeman M, Pierpont ME, Berry SA, Shanley R, Rubin N, Sommer K, Moertel CL. Social skills in children with RASopathies: a comparison of Noonan syndrome and neurofibromatosis type 1. Journal of Neurodevelopmental Disorders. 10: 21. PMID 29914349 DOI: 10.1186/S11689-018-9239-8 |
0.369 |
|
| 2018 |
Westenfield K, Sarafoglou K, Speltz LC, Pierpont EI, Steyermark J, Nascene D, Bower M, Pierpont ME. Mosaicism of the UDP-Galactose transporter SLC35A2 in a female causing a congenital disorder of glycosylation: a case report. Bmc Medical Genetics. 19: 100. PMID 29907092 DOI: 10.1186/S12881-018-0617-6 |
0.326 |
|
| 2018 |
Pierpont EI, McCoy E, King KE, Ziegler RS, Shanley R, Nascene D, Raymond GV, Phelan R, Lund TC, Orchard PJ, Miller WP. Post-transplant adaptive function in childhood cerebral adrenoleukodystrophy. Annals of Clinical and Translational Neurology. 5: 252-261. PMID 29560371 DOI: 10.1002/Acn3.526 |
0.329 |
|
| 2017 |
Edgin JO, Anand P, Rosser T, Pierpont EI, Figueroa C, Hamilton D, Huddleston L, Mason G, Spanò G, Toole L, Nguyen-Driver M, Capone G, Abbeduto L, Maslen C, Reeves RH, et al. The Arizona Cognitive Test Battery for Down Syndrome: Test-Retest Reliability and Practice Effects. American Journal On Intellectual and Developmental Disabilities. 122: 215-234. PMID 28452581 DOI: 10.1352/1944-7558-122.3.215 |
0.362 |
|
| 2016 |
Pierpont EI, Semrud-Clikeman M, Pierpont ME. Variability in clinical and neuropsychological features of individuals with MAP2K1 mutations. American Journal of Medical Genetics. Part A. PMID 27862862 DOI: 10.1002/Ajmg.A.38044 |
0.443 |
|
| 2016 |
Pierpont EI, Wolford M. Behavioral functioning in cardiofaciocutaneous syndrome: Risk factors and impact on parenting experience. American Journal of Medical Genetics. Part A. PMID 27149079 DOI: 10.1002/Ajmg.A.37725 |
0.334 |
|
| 2016 |
Pierpont E, Eisengart J, Ziegler R, Raymond G, Orchard PJ, Lund T, Miller WP. Neurocognitive Trajectory of Patients with Childhood Cerebral Adrenoleukodystrophy Who Received Allogeneic Hematopoietic Cell Transplantation at an Early Stage of Cerebral Disease Blood. 128: 4682-4682. DOI: 10.1182/Blood.V128.22.4682.4682 |
0.348 |
|
| 2015 |
Pierpont EI, Tworog-Dube E, Roberts AE. Attention skills and executive functioning in children with Noonan syndrome and their unaffected siblings. Developmental Medicine and Child Neurology. 57: 385-92. PMID 25366258 DOI: 10.1111/Dmcn.12621 |
0.365 |
|
| 2014 |
Pierpont ME, Magoulas PL, Adi S, Kavamura MI, Neri G, Noonan J, Pierpont EI, Reinker K, Roberts AE, Shankar S, Sullivan J, Wolford M, Conger B, Santa Cruz M, Rauen KA. Cardio-facio-cutaneous syndrome: clinical features, diagnosis, and management guidelines. Pediatrics. 134: e1149-62. PMID 25180280 DOI: 10.1542/Peds.2013-3189 |
0.336 |
|
| 2013 |
Kover ST, Pierpont EI, Kim JS, Brown WT, Abbeduto L. A neurodevelopmental perspective on the acquisition of nonverbal cognitive skills in adolescents with fragile X syndrome. Developmental Neuropsychology. 38: 445-60. PMID 24138215 DOI: 10.1080/87565641.2013.820305 |
0.393 |
|
| 2013 |
Pierpont EI, Tworog-Dube E, Roberts AE. Learning and memory in children with Noonan syndrome. American Journal of Medical Genetics. Part A. 161: 2250-7. PMID 23918208 DOI: 10.1002/Ajmg.A.36075 |
0.316 |
|
| 2011 |
Pierpont EI, Richmond EK, Abbeduto L, Kover ST, Brown WT. Contributions of phonological and verbal working memory to language development in adolescents with fragile X syndrome. Journal of Neurodevelopmental Disorders. 3: 335-47. PMID 21993552 DOI: 10.1007/S11689-011-9095-2 |
0.389 |
|
| 2010 |
Pierpont EI, Ellis Weismer S, Roberts AE, Tworog-Dube E, Pierpont ME, Mendelsohn NJ, Seidenberg MS. The language phenotype of children and adolescents with Noonan syndrome. Journal of Speech, Language, and Hearing Research : Jslhr. 53: 917-32. PMID 20543023 DOI: 10.1044/1092-4388(2009/09-0046) |
0.542 |
|
| 2010 |
Pierpont EI, Pierpont ME, Mendelsohn NJ, Roberts AE, Tworog-Dube E, Rauen KA, Seidenberg MS. Effects of germline mutations in the Ras/MAPK signaling pathway on adaptive behavior: cardiofaciocutaneous syndrome and Noonan syndrome. American Journal of Medical Genetics. Part A. 152: 591-600. PMID 20186801 DOI: 10.1002/Ajmg.A.33268 |
0.557 |
|
| 2009 |
Pierpont EI, Pierpont ME, Mendelsohn NJ, Roberts AE, Tworog-Dube E, Seidenberg MS. Genotype differences in cognitive functioning in Noonan syndrome. Genes, Brain, and Behavior. 8: 275-82. PMID 19077116 DOI: 10.1111/J.1601-183X.2008.00469.X |
0.572 |
|
| 2005 |
Ullman MT, Pierpont EI. Specific language impairment is not specific to language: the procedural deficit hypothesis. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 41: 399-433. PMID 15871604 DOI: 10.1016/S0010-9452(08)70276-4 |
0.358 |
|
| Show low-probability matches. |